Use of vanillyl-beta-d-glucopyranoside in the preparation of a drug for liver injury

CN119925397BActive Publication Date: 2025-12-05GUIZHOU MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510035931.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-01-09
Publication Date
2025-12-05
Estimated Expiration
2045-01-09

Smart Images

  • Figure CN119925397B_ABST
    Figure CN119925397B_ABST
Patent Text Reader

Abstract

The application belongs to the technical field of medicine, and particularly relates to application of vanillyl-beta-D-glucopyranoside in preparation of liver injury drugs. The application provides, for the first time, application of vanillyl-beta-D-glucopyranoside in preparation of liver injury drugs. Vanillyl-beta-D-glucopyranoside is Vanillyl-beta-D-glucopyranoside (molecular formula is C 14 H 20 O8; molecular weight is 316.3, and is referred to as VA hereinafter). The drug VA does not show toxicity in a concentration range (6.25-100 muM) under investigation, can significantly improve cell survival rate of liver parenchymal cells AML-12 induced by acetaminophen, has a significant liver protection effect, and has a good application prospect in preparation of liver injury prevention and treatment drugs.
Need to check novelty before this filing date? Find Prior Art